GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)
China flag China · Delayed Price · Currency is CNY
11.92
-0.28 (-2.30%)
Nov 18, 2026, 3:00 PM CST

SHA:600771 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
63.2263.0474.4590.08-250.02-316.24
Depreciation & Amortization
44.5244.5253.5446.0139.2538.39
Other Amortization
4.054.050.612.553.123.14
Loss (Gain) From Sale of Assets
--0.02-0.20.02-0.4
Asset Writedown & Restructuring Costs
18.9118.914.710.0219.890.03
Loss (Gain) From Sale of Investments
2.262.267.73-1.450.924.22
Provision & Write-off of Bad Debts
-0.08-0.0869.3624.7622.2-26.03
Other Operating Activities
33.989.1423.6923.0851.848.14
Change in Accounts Receivable
-82.05-82.05289.01221.08352.25228.78
Change in Inventory
10.9810.98-204.87-157.6-59.639.76
Change in Accounts Payable
126.45126.45-190.49-25.6686.1155.62
Operating Cash Flow
222.92197.89112.39215.5253.4381.37
Operating Cash Flow Growth
25.50%76.07%-47.85%-14.96%211.45%-

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7.6-6.24-8.78-2.51-8.67-18.19
Sale of Property, Plant & Equipment
--0.040.230.030
Investment in Securities
9.33-0.141.560.350.2-0.55
Other Investing Activities
-155.18-10.17-0.741.020.86
Investing Cash Flow
-153.45-16.55-7.17-1.19-7.41-17.89

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-19.9411.77-51.62206.5
Long-Term Debt Issued
---56355301.86
Total Debt Issued
19.9419.9411.7756406.62508.36
Short-Term Debt Repaid
-----229.5-288.22
Long-Term Debt Repaid
--18.53-254.37-242.98-260.32-309.8
Lease Payments
-10.39-10.39-8.77-7.78-1.26-
Total Debt Repaid
-18.53-18.53-254.37-242.98-489.82-598.02
Net Debt Issued (Repaid)
1.411.41-242.61-186.98-83.19-89.67
Common Dividends Paid
-1.19-1.19-3.95-14.33-19.8-18.31
Other Financing Activities
-37.91-0.22-0.23---
Financing Cash Flow
-37.690-246.78-201.31-102.99-107.98

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
31.78181.34-141.5613143.03-44.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
215.32191.65103.61212.99244.7663.17
Free Cash Flow Growth
27.45%84.97%-51.35%-12.98%287.44%-
Free Cash Flow Margin
16.41%14.00%8.48%16.59%21.65%7.40%
Free Cash Flow Per Share
0.380.400.180.430.500.13
Levered Free Cash Flow
229.01195.4383.83164.65553.83-124.2
Unlevered Free Cash Flow
230.2419787.85175.23566.93-112.27
Free Cash Flow After Leases
204.93181.2694.84205.21243.563.17

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
178.13185.57144.31142.15111.09126.71
Change in Working Capital
56.0456.04-121.7230.64366.21370.13